Xilio Therapeutics (XLO) Institutional Ownership → Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (From InvestorPlace) (Ad) Free XLO Stock Alerts $1.14 +0.06 (+5.56%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Xilio Therapeutics (NASDAQ:XLO)CurrentInstitutional OwnershipPercentage54.29%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$32.40KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$2.20M Skip Chart & View Institutional Buying and Selling Data XLO Institutional Buying and Selling by Quarter Ad InvestorPlaceBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Xilio Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/6/2024 Atlas Venture Life Science Advisors LLC992,912$1.07M0.1%-64.0%2.690% 4/22/2024 PFG Investments LLC30,000$32K0.0%N/A0.087% 2/15/2024 Octagon Capital Advisors LP1,785,000$982K0.2%-23.0%6.481% 11/14/2022Ergoteles LLC12,941$38K0.0%-26.3%0.047% 8/15/2022 Laurion Capital Management LP142,900$417K0.0%N/A0.520% 7/27/2022 Bailard Inc.36,632$107K0.0%N/A0.133% 5/16/2022 Deerfield Management Company L.P. Series C2,078,692$14.70M0.3%-3.5%7.567% 5/12/2022 Monashee Investment Management LLC163,066$1.15M0.3%-23.9%0.594% 2/15/2022Davidson Kempner Capital Management LP29,000$458K0.0%N/A0.109% 2/14/2022 Deerfield Management Company L.P. Series C2,154,061$33.74M0.7%N/A8.078% 2/14/2022 Ghisallo Capital Management LLC30,000$480K0.0%N/A0.113% 2/14/2022 Soleus Capital Management L.P.477,495$7.64M0.8%N/A1.791% 2/11/2022Granite Point Capital Management L.P.10,000$160K0.0%N/A0.038% 2/9/2022AJU IB Investment Co. Ltd.667,742$10.68M14.9%N/A2.504% 2/8/2022 Northern Trust Corp63,034$1.01M0.0%N/A0.236% 2/7/2022 Monashee Investment Management LLC214,253$3.43M0.8%N/A0.803% 2/7/2022 RiverVest Venture Management LLC1,441,444$23.06M16.5%N/A5.406% 2/2/2022 New York State Common Retirement Fund5,568$89K0.0%N/A0.021% (Data available from 1/1/2016 forward) XLO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of XLO shares? During the previous two years, the following institutional investors and hedge funds held shares of Xilio Therapeutics shares: Atlas Venture Life Science Advisors LLC ($1.07M), Octagon Capital Advisors LP ($982K), Laurion Capital Management LP ($417K), Bailard Inc. ($107K), and Ergoteles LLC ($38K), PFG Investments LLC ($32K).Learn more on XLO's institutional investors. What percentage of Xilio Therapeutics stock is owned by institutional investors? 54.29% of Xilio Therapeutics stock is owned by institutional investors. Learn more on XLO's institutional investor holdings. Which institutional investors have been buying Xilio Therapeutics stock? The following institutional investors have purchased Xilio Therapeutics stock in the last 24 months: Laurion Capital Management LP ($142.90K), Bailard Inc. ($36.63K), and PFG Investments LLC ($30K). How much institutional buying is happening at Xilio Therapeutics? Institutional investors have bought a total of 209,532 shares in the last 24 months. This purchase volume represents approximately $556.63K in transactions. Which Xilio Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Xilio Therapeutics stock in the last 24 months: Atlas Venture Life Science Advisors LLC ($1.77M), Octagon Capital Advisors LP ($533.50K), and Ergoteles LLC ($4.61K). How much institutional selling is happening at Xilio Therapeutics? Institutional investors have sold a total of 2,304,539 shares in the last 24 months. This volume of shares sold represents approximately $2.21M in transactions. Related Companies: LEXX Institutional Ownership CARA Institutional Ownership UNCY Institutional Ownership VYNE Institutional Ownership CASI Institutional Ownership EYEN Institutional Ownership GANX Institutional Ownership SNSE Institutional Ownership PMN Institutional Ownership HCWB Institutional Ownership This page (NASDAQ:XLO) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist My Default Watchlist Adding Xilio Therapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.